• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and breastfeeding is a challenge for women suffering from the condition. There aren't enough data regarding how exposure over time may affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological issues such as impaired hearing or vision, febrile seizures or IQ impairment. The authors acknowledge that more high quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against the potential risks to the fetus. Doctors don't have the necessary data to make unequivocal recommendations, but they can provide information on risks and benefits that assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications in early pregnancy did not face a significantly increased risk of fetal heart malformations or major structural birth defects. Researchers used a vast population-based study of case-control to assess the risk of major structural birth defects in infants born to mothers who had taken stimulants in early pregnancy, and those who did not. Pediatric cardiologists and clinical geneticists looked over the cases to ensure correct case classification and to limit the chance of bias.

The study of the researchers had some limitations. In particular, they were unable to separate the effects of the medication from the disorder that is underlying. This limitation makes it difficult for researchers to establish whether the small associations observed among the groups exposed were due to the use of medication, or if they were caused by co-morbidities. The researchers also did not study the long-term effects for the offspring.

The study did reveal that babies whose mothers had taken ADHD medications during pregnancy were at a slightly more risk of being admitted to the neonatal intensive care unit (NICU) than infants whose mothers had not taken any medication or had cut back on their medications prior to or during pregnancy. This was due to central nervous system disorders. The higher risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher risk of having to have a caesarean section or the baby was not scoring well on the Apgar scale (less than 7). These increases appear to be independent of the type of medication used during pregnancy.

The research suggests that the risk of a small amount with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits to both mother and child from continued treatment for the woman's disorder. Physicians should talk to their patients about this and try to help them develop coping skills that could reduce the effects of her disorder on her daily functioning and her relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to continue treatment or stop as more women are diagnosed with ADHD. These decisions are frequently taken without clear and authoritative evidence. Instead, physicians must consider their own expertise in conjunction with the experiences of other doctors and the research on the topic.

The issue of possible risks to the infant can be extremely difficult. The research on this subject is based on observations rather than controlled studies and a lot of the results are conflicting. Most studies focus on live births, which can underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these issues by examining data on both live and deceased births.

The conclusion The conclusion: While some studies have found an association between treating adhd without medication medications and the risk of certain birth defects, [empty] others have found no connection, and most studies show a neutral or even slightly negative effect. In all cases an in-depth evaluation of the risks and benefits must be performed.

For women suffering from ADHD, the decision to stop taking medication can be difficult, if not impossible. In a recent article published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can cause depression and feelings of being isolated. A decrease in medication could also impact the ability to safely drive and complete work-related tasks, which are vital aspects of everyday life for those suffering from ADHD.

She suggests that women who aren't sure whether to continue taking medication or stop it due to their pregnancy, educate their family members, coworkers and their friends about the condition, its impact on daily functioning and the advantages of staying on the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported as she struggles with her decision. Some medications can pass through the placenta. If a woman decides to not take her ADHD medication while breastfeeding, it is important to be aware that the drug could be transferred to the infant.

Birth Defects and Risk of

As the use of ADHD drugs to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases there are concerns about what impact the drugs might have on the fetuses. A study that was published in the journal Molecular Psychiatry adds to the existing knowledge on this subject. With two massive data sets, researchers were able to look at more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers found that while the risk overall is low, first-trimester ADHD exposure to medication was associated with slightly higher risk of certain heart defects, such as ventriculoseptal defect.

The authors of the study could not discover any link between the use of early medications and congenital anomalies like facial deformities, or club feet. The results are consistent with previous studies that have shown a small but significant increase in the risk of heart malformations among women who started taking ADHD medications prior to the time of the birth of their child. The risk was higher in the latter half of pregnancy, as many women decide to stop taking their ADHD medications.

Women who were taking ADHD medication during the first trimester were more likely to require a caesarean birth and also have a low Apgar after delivery and have a baby who needed breathing assistance at birth. However, the authors of the study were unable to eliminate bias due to selection by restricting the study to women who didn't have other medical issues that could have contributed to the findings.

The researchers hope their study will serve to inform the clinical decisions of physicians who treat pregnant women. The researchers advise that while discussing benefits and risks are important, the choice on whether to continue or stop medication should be made according to the severity of each woman's adhd non stimulant medication uk symptoms and the needs of the woman.

The authors also warn that while discontinuing the medications is an option, it is not an option that is recommended due to the high rate of depression and other mental health issues for women who are expecting or postpartum. Furthermore, research suggests that women who decide to stop taking their medications are more likely to experience difficulties getting used to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD who must work through their symptoms while attending doctor appointments, making preparations for the arrival of their child and adapting to new routines in the home are often faced with a number of difficulties. Many women choose to continue taking their ADHD medication during pregnancy.

The majority of stimulant medicines are absorbed by breast milk in small amounts, therefore the risk to breastfeeding infant is minimal. However, the rate of exposure to medications by the newborn may differ based on dosage, how often it is administered and the time of day it is administered. Additionally, individual medications enter the body of the baby differently through the gastrointestinal tract and breast milk and the impact of this on a newborn is not fully known.

Some doctors may decide to stop stimulant medication during a woman’s pregnancy due to the absence of research. This is a difficult choice for the patient, who must weigh the benefits of keeping her medication against the potential risks to the fetus. As long as more information is available, doctors may ask pregnant patients whether they have any background of ADHD or if they intend to take medication during the perinatal period.

Many studies have shown that women can continue to take their best adhd medication for adults uk medication safely while breastfeeding and during pregnancy. In the end, more and more patients opt to do this and, after consulting with their doctor, they have discovered that the benefits of maintaining their current medication far outweigh any potential risks.

Women with ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should review their medications with their prescriber and discuss the pros and cons of continued treatment, including non-pharmacological strategies. Psychoeducation should also be offered to help pregnant women suffering from ADHD be aware of their symptoms and the underlying disorder Learn about the available treatment options and reinforce existing strategies for managing. This should involve an approach that is multidisciplinary, including the GP as well as obstetricians, psychiatry and obstetricians. Counselling for pregnancy should include discussion of a management plan for both the mother as well as the child, as well as monitoring for signs of deterioration and, if necessary, adjustments to the medication regimen.